124 related articles for article (PubMed ID: 38904964)
1. Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial.
Fehlings MG; Pedro KM; Alvi MA; Badhiwala JH; Ahn H; Farhadi HF; Shaffrey CI; Nassr A; Mummaneni P; Arnold PM; Jacobs WB; Riew KD; Kelly M; Brodke DS; Vaccaro AR; Hilibrand AS; Wilson J; Harrop JS; Yoon ST; Kim KD; Fourney DR; Santaguida C; Massicotte EM; Huang P
JAMA Netw Open; 2024 Jun; 7(6):e2415643. PubMed ID: 38904964
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Fehlings MG; Badhiwala JH; Ahn H; Farhadi HF; Shaffrey CI; Nassr A; Mummaneni P; Arnold PM; Jacobs WB; Riew KD; Kelly M; Brodke DS; Vaccaro AR; Hilibrand AS; Wilson J; Harrop JS; Yoon ST; Kim KD; Fourney DR; Santaguida C; Massicotte EM; Kopjar B
Lancet Neurol; 2021 Feb; 20(2):98-106. PubMed ID: 33357512
[TBL] [Abstract][Full Text] [Related]
3. Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.
Lubelski D; Alvin MD; Nesterenko S; Sundar SJ; Thompson NR; Benzel EC; Mroz TE
J Neurosurg Spine; 2016 Mar; 24(3):483-9. PubMed ID: 26613280
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial.
Fehlings MG; Wilson JR; Karadimas SK; Arnold PM; Kopjar B
Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S68-75. PubMed ID: 23962993
[TBL] [Abstract][Full Text] [Related]
5. Arthroplasty for cervical spondylotic myelopathy: similar results to patients with only radiculopathy at 3 years' follow-up.
Fay LY; Huang WC; Wu JC; Chang HK; Tsai TY; Ko CC; Tu TH; Wu CL; Cheng H
J Neurosurg Spine; 2014 Sep; 21(3):400-10. PubMed ID: 24926929
[TBL] [Abstract][Full Text] [Related]
6. Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy.
Karadimas SK; Laliberte AM; Tetreault L; Chung YS; Arnold P; Foltz WD; Fehlings MG
Sci Transl Med; 2015 Dec; 7(316):316ra194. PubMed ID: 26631633
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial.
Ghogawala Z; Terrin N; Dunbar MR; Breeze JL; Freund KM; Kanter AS; Mummaneni PV; Bisson EF; Barker FG; Schwartz JS; Harrop JS; Magge SN; Heary RF; Fehlings MG; Albert TJ; Arnold PM; Riew KD; Steinmetz MP; Wang MC; Whitmore RG; Heller JG; Benzel EC
JAMA; 2021 Mar; 325(10):942-951. PubMed ID: 33687463
[TBL] [Abstract][Full Text] [Related]
8. Anterior versus posterior surgical approaches to treat cervical spondylotic myelopathy: outcomes of the prospective multicenter AOSpine North America CSM study in 264 patients.
Fehlings MG; Barry S; Kopjar B; Yoon ST; Arnold P; Massicotte EM; Vaccaro A; Brodke DS; Shaffrey C; Smith JS; Woodard E; Banco RJ; Chapman J; Janssen M; Bono C; Sasso R; Dekutoski M; Gokaslan ZL
Spine (Phila Pa 1976); 2013 Dec; 38(26):2247-52. PubMed ID: 24108289
[TBL] [Abstract][Full Text] [Related]
9. Impact of dynamic alignment, motion, and center of rotation on myelopathy grade and regional disability in cervical spondylotic myelopathy.
Liu S; Lafage R; Smith JS; Protopsaltis TS; Lafage VC; Challier V; Shaffrey CI; Radcliff K; Arnold PM; Chapman JR; Schwab FJ; Massicotte EM; Yoon ST; Fehlings MG; Ames CP
J Neurosurg Spine; 2015 Dec; 23(6):690-700. PubMed ID: 26315953
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Surgery for Mild Degenerative Cervical Myelopathy: Results of the AOSpine North America and International Prospective Multicenter Studies.
Badhiwala JH; Witiw CD; Nassiri F; Akbar MA; Mansouri A; Wilson JR; Fehlings MG
Neurosurgery; 2019 Apr; 84(4):890-897. PubMed ID: 29684181
[TBL] [Abstract][Full Text] [Related]
11. Geographic variations in clinical presentation and outcomes of decompressive surgery in patients with symptomatic degenerative cervical myelopathy: analysis of a prospective, international multicenter cohort study of 757 patients.
Fehlings MG; Kopjar B; Ibrahim A; Tetreault LA; Arnold PM; Defino H; Kale SS; Yoon ST; Barbagallo GM; Bartels RHM; Zhou Q; Vaccaro AR; Zileli M; Tan G; Yukawa Y; Brodke DS; Shaffrey CI; Santos de Moraes O; Woodard EJ; Scerrati M; Tanaka M; Toyone T; Sasso RC; Janssen ME; Gokaslan ZL; Alvarado M; Bolger C; Bono CM; Dekutoski MB
Spine J; 2018 Apr; 18(4):593-605. PubMed ID: 28888674
[TBL] [Abstract][Full Text] [Related]
12. Comparison of posterior muscle-preserving selective laminectomy and laminectomy with fusion for treating cervical spondylotic myelopathy: study protocol for a randomized controlled trial.
MacDowall A; Löfgren H; Edström E; Brisby H; Parai C; Elmi-Terander A
Trials; 2023 Feb; 24(1):106. PubMed ID: 36765352
[TBL] [Abstract][Full Text] [Related]
13. Patient phenotypes associated with outcome following surgery for mild degenerative cervical myelopathy: a principal component regression analysis.
Badhiwala JH; Witiw CD; Nassiri F; Jaja BNR; Akbar MA; Mansouri A; Merali Z; Ibrahim GM; Wilson JR; Fehlings MG
Spine J; 2018 Dec; 18(12):2220-2231. PubMed ID: 29746963
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Riluzole as a pharmacotherapeutic treatment option for early cervical myelopathy: a double-blinded, placebo-controlled randomised controlled trial.
Rajasekaran S; Aiyer SN; Shetty AP; Kanna RM; Maheswaran A; Shetty JY
Eur Spine J; 2016 Jun; 25(6):1830-5. PubMed ID: 26596730
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Outcomes of Surgical Treatment for Ossification of the Posterior Longitudinal Ligament Versus Other Forms of Degenerative Cervical Myelopathy: Results from the Prospective, Multicenter AOSpine CSM-International Study of 479 Patients.
Nakashima H; Tetreault L; Nagoshi N; Nouri A; Arnold P; Yukawa Y; Toyone T; Tanaka M; Zhou Q; Fehlings MG
J Bone Joint Surg Am; 2016 Mar; 98(5):370-8. PubMed ID: 26935459
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Surgical Decompression in Patients With Degenerative Cervical Myelopathy: Results of the Canadian Prospective Multicenter Study.
Karim SM; Cadotte DW; Wilson JR; Kwon BK; Jacobs WB; Johnson MG; Paquet J; Bailey CS; Christie SD; Nataraj A; Attabib N; Phan P; McIntosh G; Hall H; Rampersaud YR; Manson N; Thomas KC; Fisher CG; Dea N
Neurosurgery; 2021 Oct; 89(5):844-851. PubMed ID: 34382661
[TBL] [Abstract][Full Text] [Related]
17. Mild diabetes is not a contraindication for surgical decompression in cervical spondylotic myelopathy: results of the AOSpine North America multicenter prospective study (CSM).
Arnold PM; Fehlings MG; Kopjar B; Yoon ST; Massicotte EM; Vaccaro AR; Brodke DS; Shaffrey CI; Smith JS; Woodard EJ; Banco RJ; Chapman JR; Janssen ME; Bono CM; Sasso RC; Dekutoski MB; Gokaslan ZL
Spine J; 2014 Jan; 14(1):65-72. PubMed ID: 23981820
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of frailty on the outcomes of surgery for degenerative cervical myelopathy: results from a prospective multicenter international data set of 757 patients.
Wilson JRF; Badhiwala JH; Moghaddamjou A; Vaccaro AR; Arnold PM; Bartels RHMA; Barbagallo G; Fehlings MG
J Neurosurg Spine; 2023 Dec; 39(6):815-821. PubMed ID: 37728372
[TBL] [Abstract][Full Text] [Related]
19. Remote motor system metabolic profile and surgery outcome in cervical spondylotic myelopathy.
Craciunas SC; Gorgan MR; Ianosi B; Lee P; Burris J; Cirstea CM
J Neurosurg Spine; 2017 Jun; 26(6):668-678. PubMed ID: 28304238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
